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Abstract
Background: Uric acid (UA) is a complex phenotype influenced by both genetic and environmental factors as well
as their interactions. Current genome-wide association studies (GWASs) have identified a variety of genetic
determinants of UA in Europeans; however, such studies in Asians, especially in Chinese populations remain limited.
Methods: A two-stage GWAS was performed to identify single nucleotide polymorphisms (SNPs) that were
associated with serum uric acid (UA) in a Chinese population of 12,281 participants (GWAS discovery stage included
1452 participants from the Dongfeng-Tongji cohort (DFTJ-cohort) and 1999 participants from the Fangchenggang
Area Male Health and Examination Survey (FAMHES). The validation stage included another independent 8830
individuals from the DFTJ-cohort). Affymetrix Genome-Wide Human SNP Array 6.0 chips and Illumina Omni-Express
platform were used for genotyping for DFTJ-cohort and FAMHES, respectively. Gene-environment interactions on
serum UA levels were further explored in 10,282 participants from the DFTJ-cohort.
Results: Briefly, we identified two previously reported UA loci of SLC2A9 (rs11722228, combined P = 8.98 × 10
-31)
and ABCG2 (rs2231142, combined P = 3.34 × 10
-42). The two independent SNPs rs11722228 and rs2231142
explained 1.03% and 1.09% of the total variation of UA levels, respectively. Heterogeneity was observed across
different populations. More importantly, both independent SNPs rs11722228 and rs2231142 were nominally
significantly interacted with gender on serum UA levels (P for interaction = 4.0 × 10
-2 and 2.0 × 10
-2, respectively).
The minor allele (T) for rs11722228 in SLC2A9 has greater influence in elevating serum UA levels in females
compared to males and the minor allele (T) of rs2231142 in ABCG2 had stronger effects on serum UA levels in
males than that in females.
Conclusions: Two genetic loci (SLC2A9 and ABCG2) were confirmed to be associated with serum UA concentration.
These findings strongly support the evidence that SLC2A9 and ABCG2 function in UA metabolism across human
populations. Furthermore, we observed these associations are modified by gender.
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Uric acid (UA) is the primary end-product of purine me-
tabolism in human beings. Most of the UA is derived
from the metabolism of endogenous purine including
cell turnover and synthesis. The UA excretion and re-
absorption is mostly in kidney [1,2]. The UA concentra-
tion in human blood is more than fifty times higher than
that in other mammals, because in most of the animals
UA could be further catalyzed to allantoin by urate oxi-
dase or uricase (the copper-binding enzyme) [1,3]; how-
ever, human beings lack uricase and have higher UA
levels which could result in hyperuricemia and gouty
arthritis [4]. UA could serve as an antioxidant by remov-
ing singlet oxygen and radicals [5]. However, elevated
UA concentration can lead to a variety of disorders,
including gout, hypertension, metabolic syndrome, dia-
betes mellitus, and cardiovascular disease [6-10].
It is indicated that the conventional factors including
age, body mass index (BMI), alcohol consumption, and
cigarette smoking could influence serum UA concentra-
tions [11-16]. In addition, serum UA levels were also de-
termined by genetic factors with heritability ranged from
25% to 63% [17-19]. Recent GWASs have identified
multiple loci of ABCG2, SLC2A9, SLC17A1, SLC16A9,
SLC22A11, GCKR, PDZK1, GCKR, RREB1, LRRC16A,
WDR1, TRIM46, INHBB, SFMBT1, TMEM171, VEGFA,
BAZ1B, PRKAG2, STC1, HNF4G, A1CF, ATXN2, UBE2Q2,
IGF1R, NFAT5, MAF, HLF, ACVR1B-ACVRL1,a n d
B3GNT4 associated with UA levels in European [20-26].
However, only two GWA studies have been conducted in
Asians [26,27]. In addition, previous study indicated that
the serum UA concentration was influenced by gene-
environmental interactions [22]. In order to investigate
the genetic determines of serum UA in Asians, especially
in Chinese, we conducted a GWA study in 3,451 individ-
uals, and subsequently replicated the top SNPs in add-
itional 8,830 healthy participants. In addition, we further
examined whether the top SNPs interacted with gender,
BMI, alcohol drinking, and cigarette smoking in determin-
ing serum UA levels respectively.
Methods
Study participants
In the discovery stage, we performed a GWAS of two
studies in the Chinese Han population: the DFTJ-cohort
consisted of 1,461 healthy individuals and the FAMHES
included 2,012 Han healthy individuals aged 20 to
69 years old. The DFTJ cohort [28] and the FAMHES
[29] were described in detail elsewhere. All of the partic-
ipants included in the GWAS stage were recruited at
health check-ups without chronic diseases such as car-
diovascular disease and cancer. Briefly, the DFTJ-cohort
initiated in 2008 is a long-term prospective, population-
based cohort study designed to determine the gene-
environmental interaction on several chronic diseases
(obesity, diabetes mellitus, cardiovascular disease, etc.)
and cancer in employees from Dongfeng Motor Corpor-
ation (DMC). The FAMHES was launched in 2009 in
Fangchenggang city, Guangxi, southwest China in 2009
and enrolled 4,303 Chinese men with 17 to 88 years-old;
this study was designed to examine the genetic, environ-
mental, and their interactions on the development of
age-related chronic diseases. The 8,830 healthy individ-
uals included in the validation stage were selected from
the DFTJ-cohort excluding the initial 1,461 subjects and
had no diagnosed chronic diseases such as cardiovascu-
lar disease, cancer, and gout et al.
The detailed information about the GWAS population
and the replication samples is shown in (Additional file 1:
Table S1). All the participants provided written informed
consent and the ethical committees in the Tongji Medical
College and Guangxi Medical University approved this re-
search project.
Measurement of serum UA levels and the covariates
A baseline physical examination was conducted and
demographic information was collected via standard
questionnaire. Overnight fasting venous blood speci-
mens were obtained and serum UA levels were mea-
sured by the ARCHITECT Ci8200 automatic analyzer
(ABBOTT Laboratories. Abbott Park, Illinois, U.S.A)
using the Abbott Diagnostics reagents following the
manufacturer’s instructions in the DFTJ cohort [28] and
using automatic analyzer (Dade Behring, USA) with ori-
ginal reagents in the FAMHES study. Weight and stand-
ing height were measured with light indoor clothing
and in bare feet. Those who had smoked at least one
cigarette per day for more than half a year either cur-
rently or formerly were defined as smokers; otherwise
they were viewed as non-smokers. Alcohol drinking was
divided into two categories: drinkers and non-drinkers.
T h o s ew h oh a dd r u n ka tl e a s to n c eaw e e kf o rm o r e
than half a year either currently or formerly were de-
f i n e da sd r i n k e r s ;o t h e r w i s et h e yw e r ev i e w e da sn o n -
drinkers.
Sample genotyping and quality control
We performed the GWAS scan in 1,461 subjects from
the DFTJ-cohort using Affymetrix Genome-Wide Human
SNP Array 6.0 chips following the manufacture’sp r o t o c o l .
Totally, we genotyped 906,703 SNPs among 1,461 sub-
jects. After stringent QC filtering individuals with geno-
typing call rate < 95% were excluded (9 subjects) for
further analysis. SNPs were excluded when 1) MAF<0.01;
2) Hardy-Weinberg Equilibrium (HWE) test P-value<
0.0001; 3) SNPs call rate<95%. Finally, 658,288 SNPs in
1,452 subjects with an overall call rate of 99.68% were
used for further analysis.
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out the GWAS scan in FAMHES. There were 1,999 indi-
viduals (sample call rate >95%) included in the final stat-
istical analysis. Based on quality control criteria, SNPs
were excluded when P <0.001 for the HWE test, MAF
<0.01, or genotype call rate <95%. Finally, 709,211 SNPs
were kept for further analysis.
In the validation stage, ten SNPs were selected based
on the following criteria: 1) SNP with P<1.0 ×10
-5 for
all GWAS samples; 2) when multiple SNPs showed a
strong LD (r
2≥ 0.8), SNPs previously reported in the
literature were prior selected; 3) Clear genotyping clusters;
4) MAF≥0.05. We used the iPLEX system (Sequenom)
and/or the TaqMan assay (Applied Biosystems) [30,31] to
genotype the 10 SNPs. The primers and probes were
available upon request.
Imputation
We performed ungenotyped SNPs imputation using
MACH 1.0 software (see URLs) via LD information from
the HapMap phase II database (CHB +JPT as reference
set, 2007-08_rel22, released 2007-03-02) in the DFTJ-
cohort GWAS. Genotyped SNPs in the FAMHES GWAS
were inferred using the IMPUTE program [32], and the
reference panels used for imputation in the FAMHES
study were HapMap rel.24, build 36, CHB +JPT. The
Imputed SNPs with high genotype information content
(proper info>0.5 for IMPUTE and Rsq >0.3 for MACH)
were retained for the further association analysis. Finally,
2,468,160 SNPs were used for the further analysis.
Statistical analysis
Analysis for serum UA was performed on natural loga-
rithmic (ln)-transformed values because of skewed distri-
butions. Genome-wide association tests were performed
using the additive model by linear regression analysis
with adjustment for age, gender, BMI, cigarette smoking,
and alcohol drinking implement using PLINK1.06 [33].
The top two eigenvectors were also adjusted as covari-
ates in the linear regression analysis. Population struc-
ture was evaluated using principal components analysis
(PCA), as implemented by EIGENSTRAT software [34]
and quantile-quantile (QQ) plot was generated by using
R 2.11.1 (see URLs). Heterogeneity among the study
populations was evaluated by the I
2 statistic [35]. The
Manhattan plot of -log10 P, LD structures and haplotype
block plots were generated by using Haploview (v4.1)
[36]. The association studies with the imputation data
were performed using the ProbABEL software [37]. The
meta-analysis of the DFTJ-cohort GWAS data and
the FAMHES GWAS data was performed using a fixed-
effects meta-analysis with inverse variance weighted
method using the metal software [38]. The regional asso-
ciation plots were drawing using SNAP software [39].
The power of the present study was calculated using
the Quanto software package [40]. We used the mean of
serum UA 292.5 μmol/L, MAF values obtained from the
combined genotype dataset, and assumed an additive
genetic model with α =0.05 in two tail tests to calculate
the statistical power.
A conditional analysis was done in linear regression
model to examine the independence of the four associ-
ated SNPs in the combined data (partial r
2 indicated the
proportion of the serum UA variation explained by each
SNP). We did the conditional analysis via including the
four significant SNPs in the linear regression model
adjusting for age, gender, BMI, cigarette smoking, and
alcohol drinking in 10,282 individuals from the DFTJ-
cohort. The SNPs with P value <0.05 remained in the
multivariate model were considered to be associated
with the serum UA levels independently.
The combined dataset including the DFTJ-cohort
GWAS data and the validation stage data totaling 10,282
individuals used in gene-environment interaction ana-
lysis was tested by introducing the interaction terms
(SNP ×gender, SNP× BMI, SNP ×alcohol drinking, and
SNP ×cigarette smoking) into the model, adjusting for
the covariates including age, gender, BMI, alcohol drink-
ing, and cigarette smoking. The P value less than 0.05
for the interaction term was considered statistical signifi-
cant. Considering multiple interaction tests were con-
ducted, we further did the multiple test [41] for the
gene-environmental interaction analysis. All statistical
analyses were performed with SPSS (version 15.0; SPSS,
Chicago, IL), and SAS version 9.2 (SAS Institute, Cary,
NC, USA).
Results
Genome-wide association of serum UA levels
The demographics of the participants are displayed in
(Additional file 1: Table S1). The Q-Q plot revealed no
inflation of type I error rate due to population stratifica-
tion, with a genomic control inflation factor of 1.007
(Additional file 2: Figure S1). No heterogeneity was ob-
served for the SNPs presented in the Table 1 between the
DFTJ-cohort study and the FAMHES. As the Manhattan
plot (Figure 1) and the regional association plots
(Additional file 3: Figure S2) indicated, at the discovery
stage the ABCG2 was significantly associated with the
serum UA at a genome-wide significance level.
Totally we further investigated ten SNPs in the valid-
ation stage and four common variants were associated
with serum UA levels at a genome-wide significant level of
5×1 0
-8: SLC2A9 (rs11722228, combined P=8. 98×10
-31)
and ABCG2 (Combined P=3. 34×1 0
-42 for rs2231142)
(Table 1). Both loci of ABCG2 and SLC2A9 have been re-
ported previously [20,22,27,42]. If SNPs are in the same
locus, we chosen r
2 of SNPs less than 0.8 for further
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2 =0.168 for rs2231142 and rs4148152;
r
2=0.224 for rs2231142 and rs3114018; r
2=0. 66 9 for
rs4148152 and rs3114018). (Additional file 3: Figure S2).
However, we failed to replicate the top SNPs in the other
loci of SEC22B, CENTG2,TET2,VEGFC,a n dTNFRSF11B
in the validations stage (Additional file 4: Table S2).
The SNP rs11722228 in SLC2A9 and rs2231142 in
ABCG2 were independently associated with serum UA
levels and accounted for 1.03% and 1.09% of the serum
UA variance respectively (Additional file 5: Table S3).
Ethnic differences in major genetic variants associated
with serum UA levels
We compared the results in the present study with those
in Japanese and Europeans. As Table 2 showes, the effect
sizes of most of these loci showed consistent direction
across the populations. ABCG2 was associated with serum
UA levels across different populations. We found signifi-
cant association of serum UA with SNP rs4148152 in
ABCG2 in our study (combined P=2. 95×10
-18). How-
ever, till now we did not find any reports of this SNP in
European populations, which might be attributable to very
low MAF (0.017) in Europeans. Furthermore, the SNP
rs4148152 was in moderate LD with the SNP rs311408
in the present study (r
2=0.669) but in very low LD in
Europeans (r
2= 0.046; HapMap CEU). SNP rs12356193 in
SLC16A9, rs10480300 in PRKAG2 and rs653178 in ATXN2
were significantly associated with serum UA in European
populations but were monoallelic in Asians. Similar
findings were found for loci of SLC2A9 (rs16890979
and rs734553), SLC22A11 (rs17300741), and recently
reported new loci of TRIM46 (rs11264341), VEGFA
(rs729761), BAZ1B (rs1178977), STC1 (rs1778674),
A1CF (rs10821905), UBE2Q2 (rs1394125), and HLF
(rs7224610) [25] which were associated with serum UA in
Europeans, however, these associations were not repli-
cated in Asians (Japanese and Chinese in the present
study). This might be due to the very lower MAF in
Asians. However, the relative small sample size in the
present study limited us to detect these associations with
enough power. In addition, we failed to replicate the SNPs
rs742132 in LRRC16A, rs780094 in GCKR, rs17632159 in
TMEM171, rs17050272 in IINHBB, and rs7188445 in
MAF which were reported in European [20,25], same as
the findings in the Japanese population, albeit the MAFs
of both of the SNPs are similar between Asians and
Table 1 Genome-wide association analyses for serum uric acid levels
SNP Chr bp Genes Locus Minor/major
allele
GWAS(n=3,451) Validation(n= 8,830) Combined
(n=12,281)
MAF Effect size
(s.e.m.)
P- value
a MAF Effect size
(s.e.m.)
P
-value
a P- value
a
rs11722228 4 9524839 SLC2A9 intron T/C 0.31 0.028 (0.006) 3.68×10
-6 0.31 0.043 (0.004) 4.16×10
-26 8.98× 10
-31
rs4148152 4 89279933 ABCG2 intron C/T 0.35 −0.029 (0.006) 1.22×10
-7 0.33 −0.029 (0.004) 4.49×10
-13 2.95× 10
-18
rs3114018 4 89283605 ABCG2 intron T/G 0.38 −0.034 (0.006) 2.75×10
-9 0.38 −0.029 (0.004) 1.02×10
-12 4.49× 10
-20
rs2231142 4 89271346 ABCG2 exon T/G 0.29 0.046 (0.006) 1.19× 10
-14 0.31 0.045 (0.004) 1.01×10
-25 3.34× 10
-42
The NCBI build 36 was used as the reference genome. Chr, chromosome. MAF indicates the minor allele frequency calculated using the data from all the subjects
in the analysis. Effect size, represents the effect of a minor allele on the standardized trait (estimated coefficient of the term for the number of the minor alleles).
aLinear regression analysis adjusted for age, sex, body mass index (BMI), cigarette smoking, and alcohol drinking.
Figure 1 Manhattan plot of genome–wide association analyses for serum uric acid concentrations. The X-axis shows chromosomal
positions. Y-axis shows –log10 P-values. The red line indicates the genome-wide significance level of 5.0× 10
-8 and the blue horizontal line
corresponds to a P value of 1.0 ×10
-5.
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Our study
a(Chinese, discovery stage) Japanese European ancestry
Gene SNP Chr Position Location MAF (allele) Effect size P-value MAF (allele) Effect size P-value MAF (allele) Effect size P-value
PDZK1 rs12129861 1 144437046 5′- 0.20(A) −0.011 0.074 0.087(A) –– 0.46(A) −0.062 [20]2 . 6 8 × 1 0
-9
TRIM46 rs11264341 1 153418117 Intron 0.33(C) 0.017 4.49×10
-3 0.24(C) 0.074 [25] 9.5× 10
–4 0.43(T) −0.050 [25] 6.2×10
–19
INHBB rs17050272 2 121022910 N/A 0.45(A) 0.008 0.174 0.49(A) 0.033 [25] 4.4× 10
–2 0.43(A) 0.035 [25] 1.6×10
–10
GCKR rs780094 2 27594741 Intron 0.44(T) 0.0133 0.014 0.43(T) 0.036 [27] 5.12× 10
-6 0.42(T) 0.050 [20]1 . 4 0 × 1 0
-9
LRP2 rs2544390 2 169913092 Intron 0.49(C) −0.001 0.73 0.49(C) −0.082 [27] 3.74× 10
-8 0.37(T) ––
SFMBT1 rs6770152 3 53075254 N/A 0.36(T) −0.010 0.071 0.46(T) −0.016 [25] 0.31 0.42(G) 0.044 [25] 2.6×10
–16
SLC2A9 rs11722228 4 9524839 Intron 0.31(T) 0.028 3.68×10
-6 0.45(T) 0.164 [27]7 . 0 9 × 1 0
-24 0.50(T) 0.167 [20] 1.75×10
-75
SLC2A9 rs16890979 4 9531265 Exon 0.02(T) −0.024 0.285 0.01(T) −0.178 [27] 3.07× 10
-2 0.29(T) −0.340 [20] 3.55× 10
-189
SLC2A9 rs734553 4 9532102 Intron 0.02(C) −0.023 0.286 0.006(C) –– 0.23(C) 0.315 [20] 5.22× 10
-201
ABCG2 rs3114018 4 89283605 Intron 0.38(T) −0.034 2.75×10
-9 0.26(A) –– 0.48(G) −0.057 [20] 2.93×10
-12
ABCG2 rs2231142 4 89271347 Exon 0.29(T) 0.046 1.19× 10
-14 0.31(T) 0.121 [27]1 . 6 2 × 1 0
-13 0.11(T) 0.173 [20] 3.10×10
-26
ABCG2 rs4148152 4 89279933 Intron 0.35(C) −0.029 1.22×10
-7 0.19( C) –– 0.017(C) ––
ABCG2 rs4148155 4 89273691 Intron 0.29(A) −0.046 9.23× 10
-15 0.30(G) 0.121 [27]1 . 1 4 × 1 0
-13 0.11(A) −0.170 [20] 1.50×10
-25
TMEM171 rs17632159 5 72467238 N/A 0.31(C) −0.009 0.129 0.28(C) −0.045 [25] 0.011 0.31(C) −0.039 [25] 3.5×10
–11
VEGFA rs729761 6 43912549 N/A 0.14(T) −0.013 0.092 0.07(T) 0.002 [25] 0.97 0.30(T) −0.047 [25] 8.0×10
–16
LRRC16A rs742132 6 25715550 Intron 0.25(A) −0.001 0.8705 0.31(A) 0.008 [27] 0.609 0.30(A) 0.054 [20]8 . 5 0 × 1 0
-9
SLC17A1 rs1183201 6 25931423 Intron 0.18(A) −0.009 0.2 0.16(A) −0.063 [27] 1.73× 10
-3 0.48(A) −0.062 [20] 3.04×10
-14
SLC17A3 rs1165205 6 25978521 Intron 0.19(T) −0.010 0.139 0.16(T) −0.07 [27] 5.04× 10
-4 0.48(T) 0.060 [20] 1.60×10
-13
PRKAG2 rs10480300
b 7 151036938 Intron 0.00(T) –– 0.00(T) –– 0.28(T) 0.035 [25] 4.1× 10
–9
BAZ1B rs1178977 7 72494985 Intron 0.08(G) 0.011 0.291 0.11(G) −0.058 [25] 0.025 0.19(G) −0.047 [25] 1.2×10
–12
STC1 rs17786744 8 23832951 N/A 0.35(G) 0.0001 0.989 0.25(G) 0.018 [25] 0.32 0.42(G) 0.029 [25] 1.4× 10
–8
HNF4G rs2941484 8 76641323 3utr 0.32(T) 0.024 1.7× 10
-5 0.43(T) 0.050 [25] 1.8× 10
-3 0.44(T) 0.044 [25] 4.4×10
–17
A1CF rs10821905 10 52316099 5′near gene 0.04(A) 0.008 0.584 0.05(A) 0.075 [25] 0.042 0.18(A) 0.057 [25] 7.4×10
–17
SLC16A9 rs12356193
b 10 61083359 Intron 0.00(C) –– 0.00(C) –– 0.18(C) 0.080 [20]1 . 0 7 × 1 0
-8
SLC22A11 rs17300741 11 64088038 Intron 0.07(A) 0.018 0.087 0.03(A) 0.063 [27] 0.197 0.49(A) 0.060 [20] 6.68×10
-14
SLC22A12 rs505802 11 64113648 Intron 0.23(T) −0.008 0.196 0.18(T) −0.231 [27]1 . 0 0 × 1 0
-31 0.30(T) −0.060 [20]2 . 0 4 × 1 0
-9
SLC22A12 rs506338 11 64197496 Intron 0.23(C) −0.005 0.502 0.17(C) −0.229 [27]2 . 3 4 × 1 0
-31 0.29(T) ––
ATXN2 rs653178
b 12 110492139 Intron 0.00(C) –– 0.00(C) –– 0.49(C) 0.035 [25] 7.2×10
–12
UBE2Q2 rs1394125 15 73946038 Intron 0.008(A) 0.014 0.188 0.08(A) 0.021 [25] 0.48 0.34(A) 0.043 [25] 2.5×10
–13
IGF1R rs6598541 15 97088658 Intron 0.41(A) 0.015 9.85× 10
-3 0.50(A) 0.033 [25] 0.038 0.36(A) 0.043 [25] 4.8×10
–15
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0Table 2 Ethnic differences in major genetic variants associated with serum uric acid levels (Continued)
NFAT5 rs7193778 16 68121391 N/A 0.05(C) 0.004 0.769 0.10(C) 0.053 [25] 0.048 0.14(C) 0.046 [25] 8.2×10
–10
MAF rs7188445 16 78292488 N/A 0.27(A) −0.003 0.592 0.31(A) −0.06 [25] 4.5× 10
-4 0.33(A) −0.032 [25] 1.6× 10
–9
HLF rs7224610 17 50719787 Intron 0.13(C) 0.004 0.579 0.18(C) 0.004 [25] 0.83 0.42(C) 0.042 [25] 5.4×10
–17
The NCBI build 36 was used as the reference genome.
aSample size, 3451, the P values in Han Chinese population were from meta-analysis of two GWASs (DFTJ-cohort and FAMHES) in discovery stage; –, information
is not available.
bThese SNP is monoallelic in HapMap CHB and HapMap JPT.
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0Europeans, suggesting that there were genetic discrepancy
on serum UA levels among different ethnic groups. The
moderate effect size of these loci on serum UA levels and
the limited sample size in the present study might be an-
other potential explanation.
Interaction of SNPs with gender, BMI, cigarette smoking,
and alcohol drinking
We further explored the interactions between the two
independently-associated SNPs (rs11722228 in SLC2A9
and rs2231142 in ABCG2) and gender, BMI, cigarette
smoking, and alcohol drinking on serum UA levels in
10,282 individuals from the DFTJ-cohort. Both SNPs
rs11722228 and rs2231142 were nominally interacted
with gender on serum UA levels (P =0.04 and P =0.02,
respectively; Additional file 6: Table S4 and Figure 2).
The minor allele (T) for rs11722228 in SLC2A9 has
greater influence in elevating serum UA levels in females
compared to males (beta =0.051 in females vs. beta =
0.035 in males), similar with the previously reported re-
sults [20]. In contrast, for SNP rs2231142 in ABCG2, the
minor allele (T) had stronger effects on serum UA levels
in males than those in females (beta =0.037 in females
vs. beta =0.057 in males), consistent with the findings
in the European populations and African Americans
[20,22]. However, the gene-gender interaction altered to
null after the multiple test based on the FDR approach.
Besides, the rs11722228 accounted for 1.33% and 0.98%
and rs2231142 accounted for 0.93% and 2.25% of the
total variance of the serum UA levels for females and
males, respectively.
In addition, the SNP rs11722228 was also interacted
with alcohol drinking and cigarette smoking (P for inter-
action =0.016 and 0.035, respectively; Additional file 6:
Table S4). Considering that the SNP rs11722228 had dif-
ferent effect size on serum UA levels in males and fe-
males and in the present study 95.1% smokers and
86.7% drinkers were males, we restricted our analysis in
males. However, we failed to detect the interactions be-
tween rs11722228 and cigarette smoking and alcohol
drinking on serum UA levels anymore (data not showed),
suggesting that the SNP-smoking and the SNP-drinking
interaction was driven by the gender differences in the
serum UA concentrations.
Discussion
In this two-stage GWAS, we replicated two previously
reported loci (ABCG2 and SLC2A9) associated with
serum UA levels and found significant gene-gender in-
teractions in Chinese Han population. In addition, ethnic
differences were observed between Asian and European
populations.
SLC2A9 is located in chromosome 4p16-15.3 and en-
codes glucose transporter 9 (GLUT9) which can re-
absorb UA in renal tubules [4]. Several studies have
reported the association between SLC2A9 and serum
UA levels [20,27,43,44]. Importantly, SLC2A9 is a trans-
porter for both fructose and urate [45]. Fructose intake
could facilitate UA formation in liver via increasing pur-
ine breakdown. In addition, animal evidences indicated a
causal relationship between fructose intake, serum UA,
and metabolic syndrome [11,46,47].
ABCG2 is an UA exporter that mediates urate excretion
in the kidney. Multiple evidences indicated that the com-
mon variants in ABCG2 could reduce the transport func-
tion and result in the hyperuricemia and gout [44,48,49].
In the present study, the missense SNP rs2231142 in
ABCG2 showed the strongest association with serum UA
level. This missense SNP could result in a glutamine-to-
Figure 2 Gene-gender interactions for SLC2A9 rs11722228 and
ABCG2 rs2231142. The P-values were calculated by using natural
log transformed uric acid concentrations as dependent variable. The
Y axis represented mean of uric acid concentrations. The X axis
represented different gender groups. Multivariate adjusted model
was used to analyze the (A) interaction for SLC2A9 rs11722228 and
gender in determining uric acid concentration, (B) interaction for
ABCG2 rs2231142and gender in determining uric acid concentration.
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is highly conserved across species and the LD pattern dif-
fers in Chinese population and European population.
Comparisons of the SNPs of the association studies for
serum UA in different populations are of great interest.
The present study replicated two previously reported loci
of SLC2A9 and ABCG2 associated with serum UA levels.
SNP rs11722228 in SLC2A9 explained 1.03% variation
compared to 1.33% in Japanese population [27] and
rs2231142 in ABCG2 accounted for 1.09% of the variation
of serum UA levels in our study compared to 1.20% in
white individuals and 0.30% in African Americans [22].
Previous studies reported that variants in SLC2A9 show
the strongest effect on serum uric acid levels compared to
ABCG2 [20,22]. However, in the present study we ob-
served that the loci of ABCG2 and SLC2A9 show compar-
able amounts of explained variance (1.09% and 1.03%
respectively). Table 2 showed that there was a little differ-
ence in MAFs in both variants rs2231142 located in
ABCG2 and rs11722228 located in SLC2A9 (0.29 and
0.31) in Chinese which were different from that ob-
served in Europeans (0.11 and 0.50 respectively).
Owing to the SNPs of rs12356193 in SLC16A9,
rs10480300 in PRKAG2, and rs653178 in ATXN2 are
monoallelic in Asians, we failed to replicate the SNPs of
rs12356193, rs10480300 and rs653178 those were identi-
fied in Europeans. In addition, we found notable differ-
ences in MAFs for rs16890979 in SLC2A9, rs17300741 in
SLC22A11, rs10821906 in AICF, rs1394125 in UBE2Q2,
rs7193778 in NFAT5 and rs7224610 in HLF (0.02 , 0.07,
0.04, 0.008, 0.05, 0.13 respectively for Chinese popula-
tion and 0.29, 0.49, 0.18, 0.34, 0.14, 0.42 respectively for
European populations) Besides, both rs16890979 (r
2 =
0.005) and rs734553 (r
2 = 0.005) in the gene SLC2A9 were
in very low LD with the SNP rs11722228 in Asians com-
pared to that in European populations (r
2 = 0.202 for
rs16890979; r
2 = 0.193 for rs734553). The very low MAF
and the difference in the LD structure might partly explain
the discrepancy of the associations between the Europeans
and Asians. In addition, relative small sample size in the
present study and the moderate effect size of the loci on
serum UA levels also limited us to have enough power to
detect these associations.
Serum UA levels are lower in females than that in
males. More importantly, gene-gender interactions were
observed for the two independent SNPs of rs11722228
and rs2231142. The minor allele (T) for rs11722228 has
greater influences in elevating serum UA levels in fe-
males compared to males, consistent with the previous
study [23]. For rs2231142, the TT genotype was related
to higher UA as compared with GG and GT genotype in
both males and females. This might be due to that the
rs2231142 T allele was related to the reduced ability to
excrete UA [50]. In addition, the minor allele T allele of
rs2231142 has greater effects on the serum UA levels in
males than those in females (P for interaction = 0.02), in
consistent with the findings from the Europeans [22]. This
gender difference might be due to the specific physio-
logical characteristics in females. It is also reported that
the estrogens might increase the renal clearance of serum
UA [51], however, the mechanism underlying the gene-
gender interaction remains to be further elucidated.
To our best of knowledge, this is the first GWA study
on serum UA levels in Chinese population. Because of the
relative small sample size in the discovery stage, we might
have limited power to detect the associations of the SNPs
with small effect size and/or low MAF. However, in the
present study we identified two reported loci (SLC2A9 and
ABCG2) associated with serum UA levels, suggesting that
our study was capable of identifying significant loci associ-
ated with serum UA levels. In addition, the combined data
in our study has more than 90% statistic power to detect
the interaction between SNP rs11722228 and gender;
70.4% statistical power to detect the interaction between
SNP rs2231142 and gender on serum UA levels. Further-
more, our study confirmed the gene-gender interaction on
serum UA levels and observed that the ABCG2 and
SLC2A9 functioned differently in males and females across
different populations [20].
Conclusions
Our study replicated two loci of SLC2A9 and ABCG2 as-
sociated with serum UA levels in a Chinese Han popula-
tion. Heterogeneity was observed among different ethnic
populations. In addition, we found both the two loci inter-
acted with gender on serum UA levels. These two loci had
different effects on serum UA levels in males and females.
Further studies are needed to validate our findings and in-
vestigate the underlying mechanisms of the gene-gender
interaction.
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